ICR Group Logo
Dr. M.R.K. BAHADOOR
M

Dr. M.R.K. BAHADOOR

EMBA, HEC E.16 Paris, Cohort Ranked 1st globally by FT 2016
HEC Business School, France
Medical Oncologist in France
Medical Director, Quantum Optics Program ICRG in UAE
Email: mrkbahadoor@icrgrp.com


MD- EMBA Medical Oncologist
Dr. M.R.K. BAHADOOR
M

Dr. M.R.K. BAHADOOR

EMBA, HEC E.16 Paris, Cohort Ranked 1st globally by FT 2016
HEC Business School, France
Medical Oncologist in France
Medical Director, Quantum Optics Program ICRG in UAE
Email: mrkbahadoor@icrgrp.com


MD - EMBA Medical Oncologist

Dr. Bahadoor is the medical director of the quantum optics program. As the physician in charge of the research programs in early cancer detection led by the International Cancer Research Group (ICRG), he has been collaborating with 15 healthcare institutions/ hospitals in 5 countries in MENA & Europe.

Prior to the current position, he has acquired 6 years of experience and track record, as a medical oncologist and doctor coordinating a cancer network in France offering services to a population of 1,3 million inhabitants, recognized by the French authorities.

He received his medical degree from the Faculty of Medicine of Auvergne, Clermont Ferrand, France, and he holds French Board-certified qualifications in Medical Oncology.

He did his undergraduate training at the University Louis Pasteur Strasbourg, France (1998 to 2005) and subsequently the postgraduate training at the Faculty of Medicine of Auvergne, Clermont Ferrand, France (as a resident doctor from 2006 to 2010).

He pursued an Executive MBA from HEC Paris Business School, France in 2016. His cohort was ranked 1st EMBA globally by Financial Times in 2019. He was issued the Certification for the Entrepreneurship & Innovation program in 2015 at Babson College, Massachusetts, USA.

Dr. Bahadoor’s particular interests include the impacts of new technologies in medicine, in particular in early cancer detection and Artificial Intelligence(AI) applied to Medicine.

As a key team member involved in the development and the validation of the clinical trials with Quantum Optics technology using digital approaches for cancer detection, he has developed an acumen in AI. In 2020, he has been awarded the certification in Artificial Intelligence: Implications for Business Strategy by MIT Sloan & MIT CSAIL, Massachusetts, USA.

He has been involved in projects defined by the National Cancer Institute in France. He has contributed to the book Cancer in Africa published in 2015 and co-author in several scientific peer-reviewed publications in Medicine. He is a member of professional organizations: American Society of Clinical Oncology (ASCO), the European Society of Medical Oncology (ESMO), and the French Supportive Care Association (AFSOS).

Dr. Sharif Kullab
S

Deputy Medical Director

Dr. Sharif Kullab

MD - MSc
Dr. Sharif Kullab
S

Dr. Sharif Kullab

Deputy Medical Director

MD - MSc

Medical Doctor (M.D.), specialist in Medical Oncology, Board certified (French General Medical Council and MRCP UK). He is also certified from Gustave Roussy Institute / Paris Universities with:

Certificate of Clinical Carcinology (DUCC) / Gustave Roussy Institute (IGR) at Villejuif, Paris (Faculty of Medicine Paris Sud 11), France.
Certificate of Thoracic Oncology (Marseille, Strasbourg, Montpellier), University of Montpellier1, France.
Certificate of Breast Diseases, Breast Diseases Center – Saint Louis Hospital, University of Paris Diderot – Paris7, France.
Certificate of Specialized Medical Oncology (Attestation de Formation Spécialisée (AFS) en OncologieMedicale), Auvergne University / Clermont Ferrand/ France.
Certificate of Digestive Cancerology, University of Paris Descartes – Sorbonne Paris Cité.
European Certificate of Gynecology and Mammary Cancers, University of Paris Descartes – Sorbonne Paris Cité, Pr. Fabrice LECURU.

2009-2015

Fellow in medical oncology

Department of Medicine (Chairman: Prof. Jean-Marc Nabholtz up to 2014), Jean Perrin Comprehensive Cancer Centre of Auvergne, Clermont-Ferrand, France.

2015 - 2016:

Consultant medical oncologist

Department of Medicine, Jean Perrin Comprehensive Cancer Centre of Auvergne, Clermont-Ferrand, France.

2015 – 2016

Director, Department of Oncology

MoulinsGeneral Hospital, Moulins, France.

2016 – Present

Consultant Medical Oncologist, Oncology Center,King Saud University Medical City (KSUMC)

Acting as Deputy Medical Director of the International Cancer Research Group (ICR Group).

Dr. Kullab has a large experience in clinical research as he was actively participating asinvestigator / coinvestigator in different national and international clinical trials (META2 Study 2013, N-UTRICANCER 2012 study, PEPS 2015, CIROCO 2016, BinOcrite®, PYXEL 2016, TOPAZE 2016, Zarzio®, Study ML 22229 – Avataxer 2011, Study TVA 2011, CURRYTAX Study 2011, TENEO Study 2011, AU651 (3+3) Study 2011, NEOZOL Study 2011, MARIANNE Study 2011, ROSIA Study 2011, LUX Breast 3 Study 2011, StoRM (SNPs to Risk Metastasis) 2011, KAMILIA Study 2012, KATHERINE Study 2012, ProMETheX 2012, BELLE 2 Study, Etude PERTAIN, APHINITY Study, AcSé CRIZOTINIB study (2015-2016), ANTHALIA study (2015-2016), Belle 3 study (2015-2016), COMET study (2015-2016), MENOCOR STUDY (2015-2016), INES STUDY (2015-2016), SOLAR-1 (2015-2016),

Dr. Nasser Azli
N

Consultant, Medical Operations

Dr. Nasser Azli

MD
Dr. Nasser Azli
N

Dr. Nasser Azli

Chief Medical Officer

MD

Scientific /Medical qualifications, including specialist training

Medical Doctor (MD), specialist Radiotherapy, Medical Oncology and Clinical Oncology
Intensive course on Pharmacokinetics and Roche Insights for Leadership in London Business School.
Fluent in Arabic, English and French.

Professional experience of Dr. Azli

Clinical experience involving the hands-on management of oncology / haematology patients :

Fellowship in Radiation Oncology: IGR Villejuif.
Fellow-ship in Clinical Research: IGR Villejuif.
Junior Assistant in Medical Oncology: IGR Villejuif.
Global Study Coordinator of the International Nasopharyngeal Cancer Study Group.
Study Coordinator of the A.T.T.I.T Group: Intra-thoracic Tumour Study Group.
Assistant of Clinical Research: IGR Villejuif.

Pharmaceutical / biotech industry experience in the development of oncology / haematology products :

Independent Consultant Drug Development Oncology (from 2014-present).
Vice President and Global Therapeutic area Head for Oncology and the Covance Translational Oncology Hub Coordinator (from 2011-2014).
Translational Medicine Leader : Roche Hoffmann Basel: Early clinical development and coordination of Roche global alliance activities (from June 2004 - December 2011).
Senior Director, Wyeth Research: European Clinical Leader – Oncology (early development of five new anti-cancer drugs and Worldwide Clinical Project Leader of breast cancer program including a first in class m-TOR inhibitor and a second generation taxane (from February 2002 – to March 2004).
Director-Senior Director, Rhône Poulenc-Rorer and Aventis Pharma : Global Clinical Project Leader for the development of docetaxel for Metastatic and Early Breast Cancer (from 1992 – 2002).

Collaboration with regulatory affairs and exposure to FDA / EMA interactions :

Docetaxel (RPR-Aventis): Three NDAs with FDA and several with the top 5 EU HA (UK, France, Germany and Sweden).
CCI 779 (Wyeth): Several face to face meetings with EU HA and with FDA.
TDM-1(Roche): Several face to face meetings with EU HA and with FDA.

Managing clinical studies via CROs :

Vice President and Global Therapeutic area Head for Oncology at Covance (from 2011-2014).

Development of biologicals :

TDM-1 (Antibody drug conjugate) in MBC and Gastric cancer.
HER 3 monoclonal Antibody: Preclinical and clinical development up to POC.
Close interactions with Roche clinical teams involved in the Herceptin and Avastin development.

Scope of work of Dr. Azli

Translational and Experimental medicine.
Motivated and experienced medical oncologist with more than 20 years with three of the largest pharmaceutical companies: RPR/Aventis (now Sanofi), Roche/GNE and Wyeth/Pfizer. Lead successful Global Clinical Development of several early and late stage compounds including cytotoxics, mAb and small molecules.
Major contributor in the development and registration of Taxotere in breast cancer.
Experienced in Translational and Experimental Medicine.
Very familiar with In-Licensing process and due-diligence.
Dr. Farida Dabouz
F

ICRG - Senior Director of Global Clinical Operations

Dr. Farida Dabouz

PhD - CCRP
Dr. Farida Dabouz
F

Dr. Farida Dabouz

Director of Data Management and Clinical Operations

PhD - CCRP

Dr Dabouz has worked in international pharmaceutical companies, CROs as well as academic international oncology group, in Europe and Canada.

Dr Dabouz has more 30 years of diversified experience across functional areas with emphasis in Cinical Systems, and mainly specializing in process reenginineering and quality assessment across multiple system implementations. Farida’s current focus is helping ICRG deploy solutions and innovatve approaches to streamline processes, improve quality output and operational efficiency, and better manage information and data.

Dr. Dabouz has a strong experience in training investigators, study coordinators, nurses, project managers, CRAs, administrative assistants, QA and data managers, IT, as well as statisticians covering all data aspects, mainly demystifying statistics in clinical trials.

Dr Dabouz has a PhD in statistics and certified/active member of Society of Clinical Research Associates (affiliated since 2012 to SOCRA). This certification allows being closer to clinical sites and work with investigators’ teams on improving data quality/integrity at the source. Dr Dabouz obtained CDISC certification (ADAM, STDM) IN 2014.

Dr Dabouz is an active member of Society for Clinical data Management (affiliated since 2012 to SCDM) webinar and online committees.

Dr Dabouz participated also in CITI course development related to the role of Clinical Study Coordinators (CRC) in data management and statistics.

Mr. Haitham Al Nimer
H

Special Advisor to the Chairman & Vice President, Corporate and Government Affairs

Mr. Haitham Al Nimer

MBA
Mr. Haitham Al Nimer
H

Mr. Haitham Al Nimer

Director, Corporate and Government Affairs and Advisor to the Chairman

MBA

Master of Business Administration(MBA) in the field of Business Management, Vinayaka Missions University.

BBA from AGIU, USA in the field of Personnel Management.

Fluent in Arabic, English and Hindi.

November 2017 – Present

ICR Group

Special Advisor to the Chairman & Vice President, Corporate and Government Affairs.

July 2016 – November 2017

ICR Group

Chief Administrative Officer (CAO) and Board Member.

Jan 2014 – July 2016

Al Faisaliah Group (AFG)

Regional Corporate Admin & Government Manager, Dubai, UAE and Riyadh, KSA.

1994 – 2014

Al Faisaliah Group Co. (FMS)

Personnel , Admin&Logistics Manager, KSA and GCC countries, Jordan, Lebanon, Iraq, Syria, Egypt& UAE.

1994 – 2008

Al Faisaliah Group Co. (Megastar)

Personnel, Admin & logistics Manager.

1991 – 1992

Abdulaziz Al Majed Est.

Office Manager.

Mr. Hitham al Nimer has more than 24 years of work experiences in the Middle East & North Africa, especially in the GCC countries, which allowed him to build a very large network of Public Relations & Government Relations in the region.

He is highly skilled in the field of Human Resource Personnel Management, Administrative Affairs and Government Relations.

He is highly skilled in the field of Human Resource Personnel Management, Administrative Affairs and Government Relations.

Mrs. Suruchi Shenolikar
S

Clinical Project Manager

Mrs. Suruchi Shenolikar

M.Sc. (Microbiology)
Mrs. Suruchi Shenolikar
S

Mrs. Suruchi Shenolikar

Clinical Project Manager

M.Sc. (Microbiology)

Suruchi joined ICRG in September 2018 as Clinical Project Manager and is responsible for project planning, implementation, and the overall management of the ICRG trials.

Suruchi has over 15 years of experience in Clinical Research having worked at some of the top global companies like Quintiles Inc (now IQVIA), PPD Inc. and Cognizant Inc. (Data Management). Her expertise includes end to end project management, involving planning, coordinating project activities to ensure timely accomplishments of goals and objectives, while maintaining compliance with ICH-GCP principles & applicable regulatory guidelines.

Suruchi is adept at leading teams, having managed large teams of Clinical Research Associates, Clinical Trial Assistants & Data Managers. Additionally, during these years, she has been involved in business expansion, customer & vendor management.

Suruchi has Masters’ degree in Science (by Research) with specialization in Microbiology, from University of Mumbai, India. She has keen interest in basic science & academic research, having conducted research projects in collaboration with prestigious organizations such as National AIDS Research Institute (Pune, India), Armed Forces Medical College (Pune, India), Ruby Hall Hospital (Pune, India), University of Arizona (Tucson, USA), ICGEB (New Delhi) and Nair Hospital (Mumbai).

She has particular interest in scientific writing and has written a thesis on her research project entitled ‘Study of microorganisms causing Central Nervous System infections in HIV seropositive and seronegative patients’. She has also presented her research work at various conferences in India.

September 2018 onwards International Cancer Research Group


Clinical Project Manager.

Developing project management/monitoring SOPs & study-related documents, trackers, etc
Mentor & manage CRAs in monitoring activities, ensure completeness of monitoring reports and compliance with all applicable regulatory guidelines and GCP.
Employ expertise in study center selection, pre-study qualification, initiation, routine monitoring, and close-out, and ability to complete these responsibilities in compliance with company SOPs.
Work on complex problems in which analysis of situations or data requires in-depth evaluation of various factors, such as management of drug supplies. Recommend and implement innovative process ideas that impact clinical trials management and cost efficiency.
Act as cross-functional liaison to ensure study plans remain aligned across functional areas. Obtain medical/scientific input for protocols from biostatistics, investigators, clinical experts, and scientific advisors.
Identify, manage and supervise clinical CRO and consultant activities.
April 2009 – Feb. 2015:

Quintiles Inc (Now IQVIA)
Clinical Research Specialist (Regional Project Manager): January 2012 – February 2015
Associate Manager, Clinical Operations: April 2009 – January 2012

May 2008 – April 2009:

Cognizant Technology Solutions India Pvt. Ltd, India.
Team Leader, Clinical Data Management

May 2006 – May 2008:

Pharmaceutical Product Development (PPD) INC., India
Clinical Research Associate

May 2005 – Feb.

2006: National AIDS Research Institute, India
Research Assistant

March 2002 – June 2004:

Nair Hospital, India
Research Assistant